HSIC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Henry Schein Inc (HSIC) is not a strong buy for a beginner long-term investor at this time. While the technical indicators show some bullish signals, the lack of significant positive catalysts, neutral trading sentiment, and modest growth outlook make it less compelling. Additionally, analyst ratings and price target changes suggest mixed sentiment with limited upside potential.
The MACD is positive at 0.276, indicating a bullish trend, but it is contracting. RSI is neutral at 58.139. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 79.415, R1: 81.775, S1: 77.054, R2: 83.234, S2: 75.595. Overall, the technicals suggest a mild bullish trend but no strong momentum.
The company is a leader in the dental market and has a vast scale. Citi initiated coverage with a Buy rating and a $100 price target, highlighting the company's position in the dental and animal health sectors.
Analysts have recently lowered price targets, citing modest growth and competitive pressures in the dental market. Hedge funds and insiders show no significant trading activity. No recent news or congress trading data is available to act as a catalyst.
No financial data or valuation metrics are available for assessment. The latest quarter's performance could not be analyzed due to missing data.
Analyst sentiment is mixed. Recent upgrades and initiations include a Buy rating from Citi with a $100 price target. However, multiple firms, including UBS, Mizuho, and Evercore ISI, have lowered their price targets, reflecting cautious optimism and modest growth expectations.
